These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9194584)

  • 1. Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions.
    Bito T; Ueda M; Ito A; Ichihashi M
    J Cutan Pathol; 1997 May; 24(5):305-8. PubMed ID: 9194584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16INK4a expression in actinic keratosis and Bowen's disease.
    Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
    Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21WAF1/CIP1 expression in non-melanoma skin tumors.
    Ahmed NU; Ueda M; Ichihashi M
    J Cutan Pathol; 1997 Apr; 24(4):223-7. PubMed ID: 9138113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
    Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
    Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression.
    Bito T; Ueda M; Ahmed NU; Nagano T; Ichihashi M
    J Cutan Pathol; 1995 Oct; 22(5):427-34. PubMed ID: 8594075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of G1/S-cyclins and cyclin-dependent kinase inhibitors in actinic keratosis and squamous cell carcinoma.
    Brasanac D; Stojkovic-Filipovic J; Bosic M; Tomanovic N; Manojlovic-Gacic E
    J Cutan Pathol; 2016 Mar; 43(3):200-10. PubMed ID: 26349899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer.
    Fusi C; Materazzi S; Minocci D; Maio V; Oranges T; Massi D; Nassini R
    J Invest Dermatol; 2014 Sep; 134(9):2408-2417. PubMed ID: 24643128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma.
    Liang SB; Furihata M; Takeuchi T; Sonobe H; Ohtsuki Y
    Virchows Arch; 2001 Nov; 439(5):622-7. PubMed ID: 11764381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
    Bordbar A; Dias D; Cabral A; Beck S; Boon ME
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bcl-2 expression in epidermal keratinocytic diseases.
    Nakagawa K; Yamamura K; Maeda S; Ichihashi M
    Cancer; 1994 Sep; 74(6):1720-4. PubMed ID: 8082073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions.
    Hussein MR; Al-Badaiwy ZH; Guirguis MN
    J Cutan Pathol; 2004 Nov; 31(10):643-51. PubMed ID: 15491323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
    Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
    J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
    Hida Y; Kubo Y; Murao K; Arase S
    Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.